For patients currently using licensed injectable GLP-1 receptor agonists in the UK: Once-daily formulations include liraglutide (Victoza) [2] Once-weekly formulations include semaglutide (Ozempic), dulaglutide (Trulicity), and exenatide extended-release (Bydureon) [1] [2] If you are participating in a clinical trial involving a GLP-1 patch, you must strictly follow the specific instructions provided by the research team regarding application duration, replacement schedule, and all other aspects of use
Realistic Expectations: What a Month-by-Month Response Looks Like Month one typically brings noticeable appetite changes and the first small weight loss of one to three pounds, primarily water weight and initial fat loss
What to Expect During Maintenance and Beyond During the maintenance phase, most patients experience steady monthly weight loss ranging from 1 to 3 pounds per week, depending on diet, exercise, and individual metabolism
The Cymbiotika Difference At Cymbiotika, our mission is to empower you with the tools you need to take ownership of your health
